| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 5 |
| 1 | ALDESLEUKIN | 2 |
| 2 | CARBOPLATIN | 2 |
| 3 | CYCLOPHOSPHAMIDE | 2 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 6 | DINUTUXIMAB | 2 |
| 7 | ETOPOSIDE | 2 |
| 8 | IFOSFAMIDE | 2 |
| 9 | IFOSFAMIDE FOR INJECTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IOBENGUANE I-123 | 2 | 0.0175 |
| 1 | NAXITAMAB | 2 | 0.0080 |
| 2 | DINUTUXIMAB | 2 | 0.0023 |
| 3 | ALDESLEUKIN | 2 | 0.0016 |
| 4 | VORINOSTAT | 2 | 0.0009 |
| 5 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 6 | TOPOTECAN | 2 | 0.0003 |
| 7 | TEMOZOLOMIDE | 2 | 0.0001 |
| 8 | IFOSFAMIDE FOR INJECTION | 2 | 0.0001 |
| 9 | IRINOTECAN HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 1 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 2 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 2 | 0.0000 |
| 4 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Anti-IgE [EPC] | 2 | 0.0000 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 5 | 0.0000 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |